Skip to main content
Caplight Logo









Wellvana

Wellvana

Private
Nashville, TennesseeHealthcare & Life Scienceshttps://wellvana.com

Last Round

Series B

Extension

Jul 21, 2023

Total Funding Raised

$98.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Wellvana operates in Healthcare & Life Sciences and is based in Nashville, Tennessee. Its latest recorded funding round was a Series B Extension round in July 2023.

Wellvana is a healthcare technology company that provides an integrated software platform and value-based care enablement services to help physicians and health systems transition to risk-based models.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Revenue Cycle, EHR & EMR, Patient Engagement

Business Model

B2B2C

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Wellvana Comparables

Compare Wellvana with similar companies based on industry and business-model similarity.

Wellvana comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vytalize Health
88%
Pearl Health
85%
Equality Health
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Wellvana Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 21, 2023
Series BMar 27, 2023
VC RoundApr 27, 2022
SeedOct 31, 2018
VC RoundOct 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

FCCP Jairo Melo

Co-Founder Chief Medical Officer

Founding Team

Philips Johnson

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Wellvana Investors

Notable investors and investment history

Wellvana investors
InvestorRounds
ValtruisSeries B
First Trust Capital PartnersVC Round, Series B
Heritage GroupSeries B
Martin VenturesVC Round, Series B, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 54% MoM.

  • Jul 27, 2026

    Monthly visitors grew 193% MoM, reaching 6.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • has_revenueSep 8, 2026

    Wellvana's health system partnerships generate more than $200M in annual risk revenue.

Book a demo to see all news

For institutional investors. Book with your work email.

Wellvana Filings

Explore SEC and related filing metadata, where available.

Wellvana filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Wellvana's valuation, stock price, and market status.

Is Wellvana a public or private company?

Wellvana is a private company.

What is the current stock price of Wellvana?

Wellvana is a private company, so its shares have no public market price. Caplight tracks Wellvana's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Wellvana worth (valuation)?

Valuation information for Wellvana is not publicly available.

Can I buy Wellvana stock?

Wellvana shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Wellvana's last funding round?

Wellvana's most recent funding round was Series B Extension on July 21, 2023.

Who are the main investors in Wellvana?

Key investors in Wellvana include Valtruis, Heritage Group, Martin Ventures.

Will Wellvana IPO soon?

No public IPO plans have been announced for Wellvana.

How can I track Wellvana secondary market activity?

Caplight tracks bids, offers, and trades in Wellvana's shares on secondary markets.

Firmographic Details

HeadquartersNashville, Tennessee
Employee Range245
Year Founded2018
Last FundingJul 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?